Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by newdaydawningon Aug 26, 2019 12:11pm

85 Views

Post# 30066189

RE:Nearing the bottom?

Could you please add more colour to deal where the underwriter buys shares @ 23 cents. For starters, just how many shares were allocated under that arrangement?

consultant99 wrote: Allowing the underwriter to buy shares at 0.23 means they can take the share price down to 0.235 and still make money; if the warrants trade over 0.07 the share price can go lower ...

i think that that this financing will keep the share price “contained” for a while.
No news re the phase 2 is not helping.

I would have loved to pick up warrants at 0.04 ...